PDCD1LG2 and renal cell carcinoma: Recent studies demonstrated that PD-L2 is highly expressed in human cancers, including HNSCC [11], LUSC [12], RCC [13], pancreatic ductal adenocarcinoma (PDAC) [14], and cervical cancer [15].